BGS Beta-Gamma-Service announces US expansion plans

The techniques that BGS US will use in Pittsburgh have proven to be effective at the company’s three sites in Germany.

rendering of bgs beta-gamma-service-pa-facility
BGS Beta-Gamma-Service, a leader in the use of beta and gamma rays for radiation sterilization and radiation crosslinking, is expanding into the United States to serve customers in the medical device, pharmaceutical, and biotechnology sectors. The U.S. facility will be in Imperial, Pennsylvania, near Pittsburgh International Airport, and is scheduled to open in mid-2025. BGS was established more than 40 years ago and operates three facilities in Germany.
CREDIT: BGS BETA-GAMMA-SERVICE

BGS Beta-Gamma-Service, a leader for more than 40 years in the use of beta and gamma rays for radiation sterilization for medical devices, pharmaceutical packaging, and biotechnology products, will open its first facility in the United States next year. The new 100,000-square-foot plant will offer fully automated E-Beam sterilization and is in Imperial, Pennsylvania, near the Pittsburgh International Airport. The facility is expected to be operational in mid-2025 and will operate as BGS US LLC with Leonard Zuba, formerly vice president of sales at Raumedic Inc., as its General Manager.

“We are delighted that our initial expansion outside of Germany will be in Pittsburgh,” Zuba says. “Pittsburgh’s proximity to key markets in the Northeast, Midwest, and South makes it an excellent location for our facility. Interest from customers and prospects regarding our ability to support them in the U.S. convinced us that there is a growing demand for E-Beam technology in the United States. Government officials have been extremely helpful with accelerating the approval process for obtaining various permits.”

Bert Whitt, who has extensive experience in the radiation sterilization of medical devices, will serve as operations manager.

The motivation for expansion
For decades, ethylene oxide (EtO) sterilization has been the preferred sterilization method for medical devices in the U.S. In recent years, growing awareness of the environmental hazards associated with the technology, along with an increasingly difficult-to-obtain supply of Cobalt 60, have threatened domestic sterilization capacity. Viable alternatives such as E-Beam sterilization are not as widespread in the U.S.

“The availability of sterilization capacity poses major challenges for U.S. manufacturers of medical devices, and pharmaceutical and biotechnology products,” says Dr. Andreas Ostrowicki, the managing director of BGS Beta-Gamma-Service GmbH. “As a result, supply chain bottlenecks occur frequently. With our new plant in Pittsburgh, we are helping to meet the need for sterilization services with our ionizing radiation technology.” The new facility will be equipped with highly efficient electron accelerator technology and fully automated product handling systems.

The techniques that BGS US will use in Pittsburgh have proven to be effective at the company’s three sites in Germany. The company is one of the pioneers in the use of E-Beam technology and operated one of the first facilities of its kind. Earlier this year, the company expanded its logistics space at its original location in Wiehl, Germany, near Cologne.